apomorphine has been researched along with 6-methyl-2-(phenylethynyl)pyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergmann, R; Gasparini, F; Kuhn, R; Spooren, WP | 1 |
| Ali, U; Chen, L; Gui, ZH; Liu, J; Wang, S; Wang, Y; Zhang, QJ | 1 |
2 other study(ies) available for apomorphine and 6-methyl-2-(phenylethynyl)pyridine
| Article | Year |
|---|---|
Effects of the prototypical mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats.
Topics: Animals; Apomorphine; Dextroamphetamine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Levodopa; Male; Motor Activity; Oxidopamine; Pyridines; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Rotation | 2000 |
Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons.
Topics: Animals; Apomorphine; Dopamine; Dopamine Agonists; Electrophysiology; Excitatory Amino Acid Antagonists; Immunohistochemistry; Male; Microelectrodes; Neurons; Oxidopamine; Parkinsonian Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Dopamine; Receptors, Metabotropic Glutamate; Tyrosine 3-Monooxygenase | 2009 |